Show Notes
Marieta Theodorakopoulou reveals why excess weight is a silent but powerful driver of chronic kidney disease. With obesity rates soaring, especially among younger generations, she guides us through the mechanisms of obesity-associated renal lesions, how to tailor treatments for obese CKD patients, and what we know about the renal safety of anti-obesity drugs.
More from A pinch of salt - A podcast by ERA
For decades, “volume status” meant a (un)healthy dose of educated guessing. What if you could just look? Faeq Husain-Syed (Giessen) joins "A pinch of salt" to explain how kidney venous Doppler makes congestion visible, and whether Point-of-care Ultrasound is ready for prime time.
Heart over there, kidney over here, metabolism somebody else’s problem? Not anymore. Amaryllis Van Craenenbroeck (KU Leuven) makes the case for Cardiovascular-Kidney-Metabolic syndrome as one continuum, not three separated clinics. Four drug classes, three organs, one patient, prevention upstream, and a fair hearing for the sceptics who call it disease-mongering.
We watch creatinine rise and fall all the time, but a failing kidney allograft is more than a numbers game. Annelies de Weerd (Erasmus MC Rotterdam) covers when to call it failure, the immunosuppression taper, and helping patients through what feels like a step backwards.
Every nephrology trainee in Europe has heard about it, stressed about it, or is quietly pretending it doesn’t exist: the ESENeph. Is it a genuine European passport, or just one more exam? Hugo Diniz talks to David Lappin, about the exam’s format, its career value, and why trainees should sign up.